Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?
Forsythe, Anna, Chandiwana, David, Barth, Janina, Thabane, Marroon, Baeck, Johan, Shor, Anastasiya, Tremblay, GabrielVolume:
Volume 10
Langue:
english
Journal:
Cancer Management and Research
DOI:
10.2147/CMAR.S162714
Date:
May, 2018
Fichier:
PDF, 763 KB
english, 2018